BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events
- Written by PR Newswire
![]() |
CAMBRIDGE, Mass. and DAEJEON, South Korea, March 8, 2023 /PRNewswire/ -- BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS) by leveraging its proprietary Brain-Targeting RNAi Nanomedicine (BTRiNTM) technology to combine...
Read more: BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events